3rd Quarter - Report

MEHLMAN CONSULTING, INC. for BIOGEN IDEC INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

International tax issues, including repatriation, deferral and check the box.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Health care reform and related health care issues: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3200 (111th), S. 1679 (111th)

Health Issues HCR

Health care reform and related health care issues: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act H.R. 1427/S.726, The Promoting Innovation and Access to Life Saving Medicine Act. H.R. 1548, Pathway for Biosimilars Act.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1427 (111th), H.R. 1548 (111th), H.R. 3200 (111th), S. 726 (111th), S. 1679 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.